The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Luncheon Seminar

LS2-7

The role of Thalidomide in current Myeloma therapy - trials & real world data

Sat. Oct 13, 2018 12:15 PM - 1:00 PM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Kazuyuki Shimizu (National Hospital Organization Higashinagoya National Hospital)

Sponsor: Fujimoto Pharmaceutical Corp.

[LS2-7] The role of Thalidomide in current Myeloma therapy - trials & real world data

Wolfgang Willenbacher (Innsbruck Medical University, Innsbruck, Austria)